Marie Rosenthal, MS
Despite vaccination, people with an immunocompromising condition, particularly those with multiple sclerosis (MS), are disproportionately affected by COVID-19 compared with the general population. This was seen during the omicron era, according to information presented at the ESCMID (European Society of Clinical Microbiology and Infectious Diseases) 2024 Global Congress (formerly called ECCMID), held in Barcelona, Spain (oral abstract 0051).
Even after receiving at least three